Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective
- PMID: 16846553
- DOI: 10.1185/030079906X112552
Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective
Abstract
Objective: To evaluate the cost of lost productivity in the workplace due to allergic rhinitis compared to other selected medical conditions from an employer perspective.
Setting and participants: A total of 8267 US employees at 47 employer locations who volunteered to participate in health/wellness screenings.
Measurements: The Work Productivity Short Inventory was used to assess the impact of a predefined group of health conditions on workplace productivity for the previous 12 months. Both absenteeism and presenteeism (lost productivity while at work) were recorded. Costs were calculated using a standard hourly wage.
Results: Allergic rhinitis was the most prevalent of the selected conditions; 55% of employees reported experiencing allergic rhinitis symptoms for an average of 52.5 days, were absent 3.6 days per year due to the condition, and were unproductive 2.3 h per workday when experiencing symptoms. The mean total productivity (absenteeism + presenteeism) losses per employee per year were 593 US dollars for allergic rhinitis, 518 US dollars for high stress, 277 US dollars for migraine, 273 US dollars for depression, 269 US dollars for arthritis/rheumatism, 248 US dollars for anxiety disorder, 181 US dollars for respiratory infections, 105 US dollars for hypertension or high blood pressure, 95 US dollars for diabetes, 85 US dollars for asthma, and 40 US dollars for coronary heart disease. The mean total productivity loss per employee per year due to caregiving was 102 US dollars for pediatric respiratory infections, 85 US dollars for pediatric allergies, 49 US dollars for Alzheimer's disease, and 42 US dollars for otitis media/earache.
Conclusions: Allergies are major contributors to the total cost of health-related absenteeism and presenteeism. Payers and employers need to consider this when determining health benefits for employees.
Similar articles
-
The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.Curr Med Res Opin. 2004 Nov;20(11):1805-14. doi: 10.1185/030079904X10151. Curr Med Res Opin. 2004. PMID: 15537481
-
Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach.Med Care. 2006 Apr;44(4):352-8. doi: 10.1097/01.mlr.0000204049.30620.1e. Med Care. 2006. PMID: 16565636 Clinical Trial.
-
Association of medication adherence with workplace productivity and health-related quality of life in patients with asthma.J Asthma. 2006 Sep;43(7):521-6. doi: 10.1080/02770900600857010. J Asthma. 2006. PMID: 16939992
-
A review of methods to measure health-related productivity loss.Am J Manag Care. 2007 Apr;13(4):211-7. Am J Manag Care. 2007. PMID: 17408341 Review.
-
Economic costs of diabetes in the U.S. In 2007.Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Diabetes Care. 2008. PMID: 18308683 Review.
Cited by
-
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).Allergo J Int. 2014;23(8):282-319. doi: 10.1007/s40629-014-0032-2. Allergo J Int. 2014. PMID: 26120539 Free PMC article.
-
Socheongryong-tang for improving nasal symptoms associated with allergic rhinitis: A study protocol for a randomized, open-label, cetirizine controlled, clinical trial.Medicine (Baltimore). 2018 Aug;97(34):e11812. doi: 10.1097/MD.0000000000011812. Medicine (Baltimore). 2018. PMID: 30142767 Free PMC article. Clinical Trial.
-
Anxiety in adults with asthma during the coronavirus disease 2019 pandemic: a Canadian perspective.Allergy Asthma Clin Immunol. 2023 Aug 23;19(1):73. doi: 10.1186/s13223-023-00833-z. Allergy Asthma Clin Immunol. 2023. PMID: 37612771 Free PMC article.
-
Rationale and Design of a Panel Study Investigating Six Health Effects of Airborne Pollen: The EPOCHAL Study.Front Public Health. 2021 Jun 18;9:689248. doi: 10.3389/fpubh.2021.689248. eCollection 2021. Front Public Health. 2021. PMID: 34222186 Free PMC article.
-
Cost-effectiveness of second-generation antihistamines and montelukast in relieving allergic rhinitis nasal symptoms.Am Health Drug Benefits. 2008 Oct;1(8):26-34. Am Health Drug Benefits. 2008. PMID: 25126257 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources